Skip to main content
. 2021 Apr 13;21:401. doi: 10.1186/s12885-021-08138-3

Fig. 1.

Fig. 1

Expression levels of serum PIVKA-II in patients with HCC, benign liver diseases (BLD) and healthy controls (HC)